BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15186268)

  • 1. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
    Nagy A; Buzogany I; Kovacs G
    Histopathology; 2004 Jun; 44(6):542-6. PubMed ID: 15186268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.
    Herbers J; Schullerus D; Chudek J; Bugert P; Kanamaru H; Zeisler J; Ljungberg B; Akhtar M; Kovacs G
    J Pathol; 1998 Jan; 184(1):58-62. PubMed ID: 9582528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.
    Bugert P; Kovacs G
    Am J Pathol; 1996 Dec; 149(6):2081-8. PubMed ID: 8952540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.
    Schwerdtle RF; Winterpacht A; Störkel S; Brenner W; Hohenfellner R; Zabel B; Huber C; Decker HJ
    Cancer Res; 1997 Nov; 57(22):5009-12. PubMed ID: 9371493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of BHD in sporadic renal tumors.
    Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
    Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
    Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.
    Shridhar V; Sun QC; Miller OJ; Kalemkerian GP; Petros J; Smith DI
    Oncogene; 1997 Nov; 15(22):2727-33. PubMed ID: 9400999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC; Chen PC; Chiang H
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
    Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G
    J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma.
    Schwerdtle RF; Störkel S; Neuhaus C; Brauch H; Weidt E; Brenner W; Hohenfellner R; Huber C; Decker HJ
    Cancer Res; 1996 Jul; 56(13):2927-30. PubMed ID: 8674042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distal nephron renal tumors: microsatellite allelotype.
    Polascik TJ; Cairns P; Epstein JI; Fuzesi L; Ro JY; Marshall FF; Sidransky D; Schoenberg M
    Cancer Res; 1996 Apr; 56(8):1892-5. PubMed ID: 8620510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas.
    Bugert P; Gaul C; Weber K; Herbers J; Akhtar M; Ljungberg B; Kovacs G
    Lab Invest; 1997 Feb; 76(2):203-8. PubMed ID: 9042156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma.
    Nagy A; Zoubakov D; Stupar Z; Kovacs G
    Int J Cancer; 2004 Apr; 109(3):472-5. PubMed ID: 14961590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics of renal oncocytosis: a possible model for neoplastic progression.
    Al-Saleem T; Cairns P; Dulaimi EA; Feder M; Testa JR; Uzzo RG
    Cancer Genet Cytogenet; 2004 Jul; 152(1):23-8. PubMed ID: 15193438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
    Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G
    J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
    Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
    Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of renal oncocytoma with focus on clinical and pathobiological aspects.
    Kuroda N; Toi M; Hiroi M; Shuin T; Enzan H
    Histol Histopathol; 2003 Jul; 18(3):935-42. PubMed ID: 12792905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
    Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC
    Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.